← Eichor
Study identifier: NCT07230600 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

AD-SVF Therapy for Refractory Endometrial Infertility

Condition: Endometrium; Atrophy · Intrauterine Synechiae  ·  Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

PhasePhase 1
Planned participants10
Who can joinFemale, 22 Years to 45 Years
Healthy volunteersNo

About this study

The purpose of this study is to initially explore the efficacy of adipose-derived stromal vascular fraction (AD-SVF) therapy in the treatment of refractory endometrial infertility.

This description comes directly from the study's public registry record.

Talk to the study team

Yali Hu  ·  86-025-83106666  ·  glyyhuyali@163.com

Hui Zhu  ·  86-025-83106666  ·  zhuhui1231@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nanjing Drum Tower HospitalNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07230600